OpenURL Connection Search

Select item for more details and to access through your institution.

Evaluation of ABT-751 against childhood cancer models in vivo.
Published in:
Investigational New Drugs, 2007, v. 25, n. 4, p. 285, doi. 10.1007/s10637-007-9042-y
By:
- Christopher Morton;
- Edward Favours;
- Kimberly Mercer;
- Claire Boltz;
- Jeri Crumpton;
- Chandra Tucker;
- Catherine Billups;
- Peter Houghton
Publication type:
Article
Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium.
Published in:
2020
By:
- Kurmasheva, Raushan T.;
- Bandyopadhyay, Abhik;
- Favours, Edward;
- Pozo, Vanessa Del;
- Ghilu, Samson;
- Phelps, Doris A.;
- McGeehan, Gerard M.;
- Erickson, Stephen W.;
- Smith, Malcolm A.;
- Houghton, Peter J.
Publication type:
journal article
Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models.
Published in:
2019
By:
- Kurmasheva, Raushan T.;
- Bandyopadhyay, Abhik;
- Favours, Edward;
- Del Pozo, Vanessa;
- Ghilu, Samson;
- Phelps, Doris A.;
- Erickson, Stephen W.;
- Peer, Cody J.;
- Figg, William D.;
- Smith, Malcolm A.;
- Houghton, Peter J.
Publication type:
journal article
Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models.
Published in:
2018
By:
- Bandyopadhyay, Abhik;
- Favours, Edward;
- Phelps, Doris A.;
- Pozo, Vanessa Del;
- Ghilu, Samson;
- Kurmashev, Dias;
- Michalek, Joel;
- Trevino, Aron;
- Guttridge, Denis;
- London, Cheryl;
- Hirotani, Kenji;
- Zhang, Ling;
- Kurmasheva, Raushan T.;
- Houghton, Peter J.
Publication type:
journal article
Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program.
Published in:
2017
By:
- Kurmasheva, Raushan T.;
- Sammons, Melissa;
- Favours, Edward;
- Wu, Jianwrong;
- Kurmashev, Dias;
- Cosmopoulos, Katherine;
- Keilhack, Heike;
- Klaus, Christine R.;
- Houghton, Peter J.;
- Smith, Malcolm A.
Publication type:
journal article
Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing program.
Published in:
Pediatric Blood & Cancer, 2010, v. 55, n. 6, p. 1224, doi. 10.1002/pbc.22355
By:
- Houghton, Peter J.;
- Morton, Christopher L.;
- Kang, Min;
- Reynolds, C. Patrick;
- Billups, Catherine A.;
- Favours, Edward;
- Payne-Turner, Debbie;
- Tucker, Chandra;
- Smith, Malcolm A.
Publication type:
Article
The pediatric preclinical testing program: Description of models and early testing results.
Published in:
Pediatric Blood & Cancer, 2007, v. 49, n. 7, p. 928, doi. 10.1002/pbc.21078
By:
- Houghton, Peter J.;
- Morton, Christopher L.;
- Tucker, Chandra;
- Payne, Debbie;
- Favours, Edward;
- Cole, Claire;
- Gorlick, Richard;
- Kolb, E. Anders;
- Zhang, Wendong;
- Lock, Richard;
- Carol, Hernan;
- Tajbakhsh, Mimi;
- Reynolds, C. Patrick;
- Maris, John M.;
- Courtright, Joshua;
- Keir, Stephen T.;
- Friedman, Henry S.;
- Stopford, Charles;
- Zeidner, Joseph;
- Wu, Jianrong
Publication type:
Article

Found: 7

Evaluation of ABT-751 against childhood cancer models in vivo.

Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium.

Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models.

Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models.

Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program.

Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing program.

The pediatric preclinical testing program: Description of models and early testing results.